Australia markets closed

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
21.73-0.36 (-1.63%)
At close: 04:00PM EDT
21.52 -0.21 (-0.97%)
After hours: 06:30PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 646.93M
Enterprise value 238.02M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.24
Price/book (mrq)0.57
Enterprise value/revenue 0.82
Enterprise value/EBITDA -4.84

Trading information

Stock price history

Beta (5Y monthly) 1.45
52-week change 3-31.60%
S&P500 52-week change 328.64%
52-week high 344.09
52-week low 321.65
50-day moving average 325.08
200-day moving average 329.89

Share statistics

Avg vol (3-month) 3214.87k
Avg vol (10-day) 3244.8k
Shares outstanding 529.78M
Implied shares outstanding 629.78M
Float 819.89M
% held by insiders 131.77%
% held by institutions 149.38%
Shares short (29 Feb 2024) 4498.42k
Short ratio (29 Feb 2024) 41.93
Short % of float (29 Feb 2024) 42.96%
Short % of shares outstanding (29 Feb 2024) 41.67%
Shares short (prior month 31 Jan 2024) 4469.87k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -58.03%
Operating margin (ttm)-47.50%

Management effectiveness

Return on assets (ttm)-3.47%
Return on equity (ttm)-14.58%

Income statement

Revenue (ttm)289.21M
Revenue per share (ttm)9.71
Quarterly revenue growth (yoy)4.10%
Gross profit (ttm)N/A
EBITDA -46.55M
Net income avi to common (ttm)-167.82M
Diluted EPS (ttm)-5.63
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)424.15M
Total cash per share (mrq)14.24
Total debt (mrq)13.59M
Total debt/equity (mrq)1.20%
Current ratio (mrq)6.95
Book value per share (mrq)38.31

Cash flow statement

Operating cash flow (ttm)27M
Levered free cash flow (ttm)26.29M